Histogen (HSTO)
(Delayed Data from OTC)
$0.19 USD
-0.14 (-42.19%)
Updated Jun 20, 2024 01:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Histogen Inc. [HSTO]
Reports for Purchase
Showing records 1 - 6 ( 6 total )
Company: Histogen Inc.
Industry: Medical - Products
Company: Histogen Inc.
Industry: Medical - Products
Uncertainty Prevails as HST-003 Struggles to Enroll; Move to Under Review
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Histogen Inc.
Industry: Medical - Products
Enrollment Challenges and Re-prioritization Push Back Clinical Programs; Reiterate Buy; PT to $1.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Histogen Inc.
Industry: Medical - Products
HST 003 and Preclinical Programs Advancing, Though Somewhat Slower Than Expected; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Histogen Inc.
Industry: Medical - Products
Company: Histogen Inc.
Industry: Medical - Products
A Better Way to Regenerate Cartilage and Spinal Discs; Initiate With a Buy and $2.40 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
|